Author name: jamesbrogdon

Low Medicare Pay Rates Haven’t Affected Access For Patients

MedPAC staff regularly survey a sample of Medicare beneficiaries and privately insured patients to determine whether they are having problems getting to see a physician. In the latest survey, about 30% of Medicare beneficiaries who were looking for a new primary care physician in 2017 reported either a big or a small problem in finding […]

Low Medicare Pay Rates Haven’t Affected Access For Patients Read More »

HR 6199 Would expand usefulness of HSAs

H.R. 6199, renamed the Restoring Access to Medication and Modernizing Health Savings Accounts Act and passed by a margin of 277-142, would: Reverse the Affordable Care Act’s (ACA’s) prohibition on using tax-favored health accounts to purchase over-the-counter medical products. Treat menstrual care products as qualified medical expenses that could be purchased with all tax-advantaged health care accounts.

HR 6199 Would expand usefulness of HSAs Read More »

Thinking about Artificial Intelligence in health care

“Artificial intelligence technology will play a vital role in the success of value-based care models, and it also promises to improve clinical care, writes attorney Pamela Hepp of Buchanan, Ingersoll & Rooney. However, the adoption of AI in health care raises legal and regulatory issues, including determination of responsibility for poor outcomes, data breaches, and

Thinking about Artificial Intelligence in health care Read More »

Medicare Trust Fund to be Depleted by 2026

A Medicare Trustees report released Tuesday finds that Medicare’s trust fund will be depleted in 2026, three years earlier than last year’s report found. “The Trustees recommend that Congress and the executive branch work closely together with a sense of urgency to address the depletion of the [trust fund] and the projected growth [in spending],” the trustees

Medicare Trust Fund to be Depleted by 2026 Read More »

Number of Medicare beneficiaries paying $2k+ per year doubled since 2010

A report from the Office of the Inspector General finds the following: Total reimbursement for all brand name drugs in Part D increased 77 percent from 2011 to 2015, despite a 17 percent decrease in the number of prescriptions for these drugs. After accounting for manufacturer rebates, reimbursement for brand name drugs in Part D

Number of Medicare beneficiaries paying $2k+ per year doubled since 2010 Read More »

Scroll to Top